Sodium Glucose Transporter 2 Inhibitor Protects Against Heart Failure With Preserved Ejection Fraction: Preclinical “2‐Hit” Model Reveals Autophagy Enhancement Via AMP‐Activated Pr... by Xinyu Hu, Dan Li, Weijie Chen, Hongyu Kuang, Dan Yang, Zhiyan Gong, Yuxiang Long, Guangliang Liu, Kai Wang, Mengshi Xia, Yanping Xu, Yuehui Yin

Subjects: Get full text

Development of an Efficient Process for a Key Synthetic Intermediate of the SGLT2 Inhibitor LH-1801 by Jun Qu, Zhong Hu, Pengcheng Zhang, Hongxiang Wu, Honglan Xue, Lei Cai, Xingxing Sun, Yun Qian, Rongrong Peng, Dehua Gao

Subjects: “…SGLT2 inhibitor…”
Get full text

Perioperative prevention of euglycaemic diabetic ketoacidosis in people living with type 2 diabetes established on sodium-glucose transport-2 inhibitors – a cross-site multi-cycle... by Karl A. Romain, Jody Cheng, Seung Ho Luka Kim, Kenneth Watters, Aikaterini Theodoraki

Subjects: “…SGLT2 inhibitors…”
Get full text

Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect by O N. Kurochkina, D. A. Korotkov, A. S. Sazhina, A N. Bogomolov

Subjects: Get full text

Correction: A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review by David Aristizábal-Colorado, David Aristizábal-Colorado, David Corredor-Rengifo, David Corredor-Rengifo, Santiago Sierra-Castillo, Carolina López-Corredor, David-Alexander Vernaza-Trujillo, David-Alexander Vernaza-Trujillo, David-Alexander Vernaza-Trujillo, Danilo Weir-Restrepo, Juan S. Izquierdo-Condoy, Esteban Ortiz-Prado, Jorge Rico-Fontalvo, Jorge Rico-Fontalvo, Juan-Esteban Gómez-Mesa, Juan-Esteban Gómez-Mesa, Alin Abreu-Lomba, Wilfredo-Antonio Rivera-Martínez, Wilfredo-Antonio Rivera-Martínez

Subjects: Get full text

A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists – a comprehensive review by David Aristizábal-Colorado, David Aristizábal-Colorado, David Corredor-Rengifo, David Corredor-Rengifo, Santiago Sierra-Castillo, Carolina López-Corredor, David-Alexander Vernaza-Trujillo, David-Alexander Vernaza-Trujillo, David-Alexander Vernaza-Trujillo, Danilo Weir-Restrepo, Juan S. Izquierdo-Condoy, Esteban Ortiz-Prado, Jorge Rico-Fontalvo, Jorge Rico-Fontalvo, Juan-Esteban Gómez-Mesa, Juan-Esteban Gómez-Mesa, Alin Abreu-Lomba, Wilfredo-Antonio Rivera-Martínez, Wilfredo-Antonio Rivera-Martínez

Subjects: Get full text

Breaking new ground in heart failure management: novel therapies and future frontiers by Arbab Khalid, Paulette Rodriguez, Vasiliki Tasouli-Drakou, Abu-Bakr Ahmed, Spencer Thatcher, Jasmine K. Dugal, Aditi Singh

Subjects: Get full text

Research progress on the effect of type 2 diabetes and hypoglycemic drugs on the prognosis of patients with colorectal cancer by ZHANG Meng，LEI Xuefen，CHEN Haixia，CHEN Yixuan，JIANG Li

Subjects: Get full text

The evolution of evidence-based methods of acute myocardial infarction treatment: is there any reason for optimism in recent years? by S. Yu. Martsevich

Subjects: Get full text